EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Resistance Patterns of Urinary Tract Pathogens Isolated from Patients with Type 2 Diabetes Mellitus on Sodium Glucose Co-transporter 2 Inhibitors Admitted in a Tertiary Hospital in the Philippines:

Catheryn Rose Rudinas, Ceryl Cindy Tan

Journal of the ASEAN Federation of Endocrine Societies · 2025

DOI: 10.15605/jafes.040.02.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the ASEAN Federation of Endocrine Societies, 2025. Verfasst von Catheryn Rose Rudinas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes and Metabolism, Department of Interna Medicine, Chong Hua Hospital, Cebu City, Philippines. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Urinary Tract Infections, Drug Resistance, Bacterial. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congruent with the increasing prevalence of diabetes, a growing armamentarium of anti-diabetes medications has been introduced. Among these are sodium glucose co-transporter-2 inhibitors (SGLT2i).

Objectives

SGLT2i use has been linked to an increased incidence of urogenital infections. The study aims to compare resistance patterns of urinary tract isolates among patients with diabetes who are on SGLT2i and not on SGLT2i.Methodology. Single-center retrospective cohort study. A total of 464 patients (75 on SGLT2i, 389 not on SGLT2i) with DM type 2 and urinary tract infection were included. Urine culture results were compared.

Results

A similar pattern of urinary tract isolates was found between groups except for C. albicans being more common in the SGLT2i group. There was no significant association between the presence of resistant urinary tract pathogens and the use of SGLT2i. There was no statistically significant difference in resistance rates between groups, except for Imipenem (p = 0.015).

Conclusion

SGLT2i use per se does not play a pivotal role in mediating bacterial resistance in urinary tract pathogens among patients with DM type 2. We do not recommend for or against the use of specific antimicrobials based on SGLT2inhibitor alone. Patient’s clinical profile along with urine culture test results remain key factors in patient management

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsUrinary Tract InfectionsDrug Resistance, BacterialHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTertiary Care CentersPhilippinesAdult

Stichwörter der Autor:innen

SGLT2 inhibitorsdiabetesresistanceurinary tract infectionurine culture

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Section of Endocrinology, Diabetes and Metabolism, Department of Interna Medicine, Chong Hua Hospital, Cebu City, Philippines.

Zitieren

APA

Rudinas, C. R., & Tan, C. C. (2025). Resistance Patterns of Urinary Tract Pathogens Isolated from Patients with Type 2 Diabetes Mellitus on Sodium Glucose Co-transporter 2 Inhibitors Admitted in a Tertiary Hospital in the Philippines:. Journal of the ASEAN Federation of Endocrine Societies. https://doi.org/10.15605/jafes.040.02.17

Vancouver

Rudinas CR, Tan CC. Resistance Patterns of Urinary Tract Pathogens Isolated from Patients with Type 2 Diabetes Mellitus on Sodium Glucose Co-transporter 2 Inhibitors Admitted in a Tertiary Hospital in the Philippines:. Journal of the ASEAN Federation of Endocrine Societies. 2025. doi:10.15605/jafes.040.02.17

BibTeX
@article{Rudinas2025,
  author = {Rudinas, Catheryn Rose and Tan, Ceryl Cindy},
  title = {Resistance Patterns of Urinary Tract Pathogens Isolated from Patients with Type 2 Diabetes Mellitus on Sodium Glucose Co-transporter 2 Inhibitors Admitted in a Tertiary Hospital in the Philippines:},
  journal = {Journal of the ASEAN Federation of Endocrine Societies},
  year = {2025},
  doi = {10.15605/jafes.040.02.17}
}
Kostenlos starten →